Opiant Pharmaceuticals Price Prediction

OPNTDelisted Stock  USD 20.65  0.00  0.00%   
At this time, The value of RSI of Opiant Pharmaceuticals' share price is at 57. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Opiant Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
Opiant Pharmaceuticals stock price prediction is an act of determining the future value of Opiant Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Opiant Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Opiant Pharmaceuticals and does not consider all of the tangible or intangible factors available from Opiant Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Opiant Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Opiant Pharmaceuticals based on different types of headlines from major news networks to social media. The Opiant stock price prediction module provides an analysis of price elasticity to changes in media outlook on Opiant Pharmaceuticals over a specific investment horizon. Using Opiant Pharmaceuticals hype-based prediction, you can estimate the value of Opiant Pharmaceuticals from the perspective of Opiant Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Opiant Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Opiant Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Opiant because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Opiant Pharmaceuticals after-hype prediction price

    
  USD 20.65  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Opiant Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
17.5217.5222.72
Details
Naive
Forecast
LowNextHigh
20.3320.3320.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
20.5820.7020.81
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Opiant Pharmaceuticals. Your research has to be compared to or analyzed against Opiant Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Opiant Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Opiant Pharmaceuticals.

Opiant Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Opiant Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Opiant Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Opiant Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Opiant Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Opiant Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Opiant Pharmaceuticals' historical news coverage. Opiant Pharmaceuticals' after-hype downside and upside margins for the prediction period are 20.65 and 20.65, respectively. We have considered Opiant Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
20.65
20.65
After-hype Price
20.65
Upside
Opiant Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Opiant Pharmaceuticals is based on 3 months time horizon.

Opiant Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Opiant Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opiant Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Opiant Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
3 Events / Month
3 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
20.65
20.65
0.00 
0.00  
Notes

Opiant Pharmaceuticals Hype Timeline

Opiant Pharmaceuticals is now traded for 20.65. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Opiant is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Opiant Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 20.65. About 42.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.53. Opiant Pharmaceuticals last dividend was issued on the September 10, 2012. The entity had 1:100 split on the 31st of December 2014. Given the investment horizon of 90 days the next estimated press release will be in about 3 days.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Opiant Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Opiant Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Opiant Pharmaceuticals' future price movements. Getting to know how Opiant Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Opiant Pharmaceuticals may potentially react to the hype associated with one of its peers.

Opiant Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Opiant price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Opiant using various technical indicators. When you analyze Opiant charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Opiant Pharmaceuticals Predictive Indicators

The successful prediction of Opiant Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Opiant Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Opiant Pharmaceuticals based on analysis of Opiant Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Opiant Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Opiant Pharmaceuticals's related companies.

Story Coverage note for Opiant Pharmaceuticals

The number of cover stories for Opiant Pharmaceuticals depends on current market conditions and Opiant Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Opiant Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Opiant Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Opiant Pharmaceuticals Short Properties

Opiant Pharmaceuticals' future price predictability will typically decrease when Opiant Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Opiant Pharmaceuticals often depends not only on the future outlook of the potential Opiant Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Opiant Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding5.9 M
Cash And Short Term Investments52.9 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in Opiant Stock

If you are still planning to invest in Opiant Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opiant Pharmaceuticals' history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data